Psychedelic medicine: a re-emerging therapeutic paradigm
Kenneth W. Tupper, Evan Wood, Richard Yensen, Matthew W. Johnson
Canadian Medical Association Journal September 8, 2015 DOI: 10.1503/cmaj.141124 via OpenAlex
Summary
AI-generated from the abstractClinical research worldwide is again investigating psychedelic substances as treatments for addiction, depression, anxiety, and PTSD. This renewed interest follows a period of research that ran from the 1950s until it was terminated, and the abstract indicates that current studies are exploring these substances' therapeutic potential for those conditions.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Addiction Anxiety |
| Keywords | Posttraumatic stress Depression economics Psychiatry |
| Citations | 189 |
| Key finding | Psychedelic substances are being reinvestigated in clinical research for treating addiction, depression, anxiety, and PTSD. |
Abstract
In clinical research settings around the world, renewed investigations are taking place on the use of psychedelic substances for treating illnesses such as addiction, depression, anxiety and posttraumatic stress disorder (PTSD). Since the termination of a period of research from the 1950s to the